Novartis India Ltd. - Research Center
500672 NOVARTIND Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 12.34 | 12.34 | 12.34 | 12.34 | 12.34 |
| Share application money | - | - | -2.22 | -2.95 | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 732.48 | 763.32 | 681.58 | 701.80 | 708.39 |
| Loan funds | |||||
| Secured loans | 0.02 | - | - | - | - |
| Unsecured loans | - | - | - | - | - |
| Total | 744.84 | 775.66 | 691.70 | 711.19 | 720.73 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 13.86 | 26.85 | 32.94 | 74.81 | 85.08 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 6.92 | 7.60 | 9.29 | 10.90 | 8.80 |
| Net block | 6.94 | 19.25 | 23.65 | 63.91 | 76.28 |
| Capital work-in-progress | - | - | - | - | - |
| Investments | - | - | - | - | - |
| Net current assets | |||||
| Current assets, loans & advances | 917.99 | 963.69 | 933.92 | 938.38 | 1,001.36 |
| Less : current liabilities & provisions | 180.09 | 207.28 | 265.87 | 291.10 | 356.91 |
| Total net current assets | 737.90 | 756.41 | 668.05 | 647.28 | 644.45 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 744.84 | 775.66 | 691.70 | 711.19 | 720.73 |
| Notes: | |||||
| Book value of unquoted investments | - | - | - | - | - |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 398.38 | 419.25 | 422.34 | 431.36 | 406.30 |
| Number of equity sharesoutstanding (Lacs) | 246.91 | 246.91 | 246.91 | 246.91 | 246.91 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis